Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Sawai: Consolidated Sales Up 12.7% to \9,772 Mil.
November 25, 2002
- OTC NEWS IN BRIEF
November 25, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
November 25, 2002
- ACCJ Mounts "value of Medical Technology" PR Campaign
November 25, 2002
- WORLD NEWS IN BRIEF
November 25, 2002
- Tokai Univ. Researchers Start Up GenoDive Pharma
November 25, 2002
- Asahi Kasei: Health Care Sales Up 6.3% to \52.1 Bil.
November 25, 2002
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
November 25, 2002
- Teijin: Bonalon to Spur Business in 2nd Half
November 25, 2002
- PRESS SEMINAR
November 25, 2002
- Kyowa Hakko: Drug Sales Down 0.6% to \71.4 Bil.
November 25, 2002
- DIAGNOSTICS NEWS IN BRIEF
November 25, 2002
- Torii: Sales in 1st Half Down 7.9%
November 25, 2002
- New Drug Organization to Properly Conduct Safety Surveillance: Dr Sakaguchi
November 25, 2002
- Nippon Shinyaku: Sales, Profitability Show Signs of Recovery
November 25, 2002
- EAD Director Urges Wholesalers to Eliminate Inappropriate Trade Practices: FJPWA Seminar
November 25, 2002
- Ono: Mainstays Contribute to Sales, Profits Growth
November 25, 2002
- NEW PRODUCTS
November 25, 2002
- Dainippon: Sales Up, Profits Remain at Low Levels
November 25, 2002
- Semi-annual Business Results
November 18, 2002
ページ
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…